COVID-19 emerged as a widespread worldwide ailment in 2019, with a continued breakdown of novel gamma and lambda variants. Given the high incidence of COVID-19 …
MA Antunez, JLA Mora, VBG Curbelo - Revista Científica Cultura …, 2022 - rccd.ucf.edu.cu
La evaluación de parámetros para proyectar estrategias de recuperación, después de la Covid-19, sustenta el objetivo de este trabajo es valorar la disnea y la fatiga durante el test …
E Ünal, AA Dönmez, Fİ Çınar - Hacettepe Üniversitesi Hemşirelik …, 2023 - dergipark.org.tr
Amaç: Bu çalışmada, COVID-19'un tedavisi ve yönetimi için yürütülmüş ulusal ve uluslararası veri tabanlarında yayınlanmış Türkiye adresli girişimsel araştırmaların sistematik …
SM Biradar, B Kohima, MS Mulimani… - Biomedical and …, 2024 - biomedpharmajournal.org
Abstract Corona virus disease 2019 (Covid-19) is an acute respiratory illness caused by the Corona virus. Corona virus 2 (SARS-CoV-2) is a continuing global health crisis that has …
SARS‐CoV‐2 is a novel coronavirus and the cause of the recent pandemic; it is an enveloped β‐coronavirus. SARS‐CoV‐2 appear in the Wuhan City of China for the first time …
CT Swamy - Microbes and Infectious Diseases, 2024 - mid.journals.ekb.eg
Background: SARS-CoV-2 virus caused the COVID-19 epidemic, which eventually turned into a global pandemic. Immunomodulatory drugs used in COVID-19 treatment pave the way …
N Takemori, HK Ooi, G Imai, M Saio - Tropical Biomedicine, 2021 - msptm.org
Outbreak of SARS-CoV-2 has been declared a pandemic, which is a serious threat to human health. The disease was named coronavirus disease 2019 (COVID-19). Until now …
The latest pandemic of coronavirus disease 2019 (COVID-19), caused by the infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has brought upon the …
E Sobngwi, S Zemsi, M Guewo-Fokeng, JC Katte… - medRxiv, 2021 - medrxiv.org
Objective We aimed to compare the safety and efficacy of a doxycycline-based regimen against the national standard guidelines (Hydroxychloroquine plus Azithromycin) for the …